Gain insight into target proteinuria thresholds and their relevance in IgAN management from Dr Colbert. Learn more about IgAN pathophysiology: References: Read More
WebinarSeptember 17, 2025 from 12:00 pm to 1:00 pm EDT
This webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and… Read More
Step into an educational journey designed to deepen your understanding of IgA Nephropathy (IgAN) through an engaging, multi-format learning experience—powered by cutting-edge tools and real-world insights. Read More
In this podcast, Dr Shah discusses the link between proteinuria and microalbuminuria, and risk for rapid disease progression in ADPKD. Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.